NBHL Featured in Nikkei Biotechnology Editor’s 2025 Top Pick

An article featuring NB Health Laboratory (NBHL), published by Nikkei Biotechnology, has been selected as one of the Deputy Editor-in-Chief’s Top Picks for 2025.

The article highlights industry trends in drug discovery in Japan that left a particularly strong impression in 2025 and includes coverage of NBHL’s research and business initiatives.Being recognized by a leading life science media outlet reflects the growing attention to our efforts in advancing innovative antibody therapeutics.

NBHL remains committed to addressing unmet medical needs and contributing to the advancement of healthcare through cutting-edge antibody drug discovery and development.

▼ Read the article (Japanese)
Nikkei Biotechnology & Business